Spear Bio
PrivateLast Round
Series A
Jul 29, 2024
Total Funding Raised
$45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spear Bio is a biotechnology company that develops ultrasensitive immunoassay technology for protein biomarker detection in research and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spear Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Spear Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 29, 2024 | ||||
| Seed | Nov 29, 2023 |
Key People
Founding team and executive leadership
Spear Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A, Seed |
| Maverick Ventures | Seed, Series A |
| Yonjin Capital | Series A |
| Yonghua Capital | Seed |
| Foresite Capital | Series A |
| CDH Investments | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Presented at AD/PD 2026 and launched new neurodegenerative assays.
- Apr 9, 2026
Launched new ultra-sensitive neurodegenerative assays at AD/PD 2026.
Spear Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spear Bio's valuation, stock price, and market status.